[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Anti-Infective Therapy Market - Global Outlook and Forecast 2021-2027

April 2021 | 100 pages | ID: A00FFAF0E22DEN
Market Monitor Global

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
This report contains market size and forecasts of Anti-Infective Therapy in Global, including the following market information:

Global Anti-Infective Therapy Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global Anti-Infective Therapy market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Anti-Infective Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Anti-Infective Therapy Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global Anti-Infective Therapy Market Segment Percentages, By Type, 2020 (%)
  • Penicillin
  • Sulphonamides
  • Aminoglycosides
  • Fluoroquinolones
  • Antifungals
  • Antiprotozoal
  • Others
China Anti-Infective Therapy Market, By Application, 2016-2021, 2022-2027 ($ millions)

China Anti-Infective Therapy Market Segment Percentages, By Application, 2020 (%)
  • Home User
  • Hospitals/Clinics
  • Ambulatory Surgery Centres
  • Others
Global Anti-Infective Therapy Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global Anti-Infective Therapy Market Segment Percentages, By Region and Country, 2020 (%)
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic Countries
    • Benelux
    • Rest of Europe
  • Asia
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Rest of Asia
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Turkey
    • Israel
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa
Competitor Analysis

The report also provides analysis of leading market participants including:

Total Anti-Infective Therapy Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total Anti-Infective Therapy Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:
  • Abbott Laboratories Ltd.
  • Cipla Ltd.
  • Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris))
  • Glenmark Pharmaceuticals Limited
  • GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd)
  • Lupin Limited
  • Panacea Biotec Limited
  • Novartis AG
  • Pfizer, Inc.
  • Ranbaxy Laboratories Limited
  • Sun Pharmaceutical Industries Limited
  • AstraZeneca plc
  • Johnson & Johnson
  • WOCKHARDT
  • F. Hoffmann-La Roche Ltd
  • Sanofi
  • Merck
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Anti-Infective Therapy Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Anti-Infective Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ANTI-INFECTIVE THERAPY OVERALL MARKET SIZE

2.1 Global Anti-Infective Therapy Market Size: 2021 VS 2027
2.2 Global Anti-Infective Therapy Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Anti-Infective Therapy Players in Global Market
3.2 Top Global Anti-Infective Therapy Companies Ranked by Revenue
3.3 Global Anti-Infective Therapy Revenue by Companies
3.4 Top 3 and Top 5 Anti-Infective Therapy Companies in Global Market, by Revenue in 2020
3.5 Global Companies Anti-Infective Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Anti-Infective Therapy Players in Global Market
  3.6.1 List of Global Tier 1 Anti-Infective Therapy Companies
  3.6.2 List of Global Tier 2 and Tier 3 Anti-Infective Therapy Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Anti-Infective Therapy Market Size Markets, 2021 & 2027
  4.1.2 Penicillin
  4.1.3 Sulphonamides
  4.1.4 Aminoglycosides
  4.1.5 Fluoroquinolones
  4.1.6 Antifungals
  4.1.7 Antiprotozoal
  4.1.8 Others
4.2 By Type - Global Anti-Infective Therapy Revenue & Forecasts
  4.2.1 By Type - Global Anti-Infective Therapy Revenue, 2016-2021
  4.2.2 By Type - Global Anti-Infective Therapy Revenue, 2022-2027
  4.2.3 By Type - Global Anti-Infective Therapy Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Anti-Infective Therapy Market Size, 2021 & 2027
  5.1.2 Home User
  5.1.3 Hospitals/Clinics
  5.1.4 Ambulatory Surgery Centres
  5.1.5 Others
5.2 By Application - Global Anti-Infective Therapy Revenue & Forecasts
  5.2.1 By Application - Global Anti-Infective Therapy Revenue, 2016-2021
  5.2.2 By Application - Global Anti-Infective Therapy Revenue, 2022-2027
  5.2.3 By Application - Global Anti-Infective Therapy Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Anti-Infective Therapy Market Size, 2021 & 2027
6.2 By Region - Global Anti-Infective Therapy Revenue & Forecasts
  6.2.1 By Region - Global Anti-Infective Therapy Revenue, 2016-2021
  6.2.2 By Region - Global Anti-Infective Therapy Revenue, 2022-2027
  6.2.3 By Region - Global Anti-Infective Therapy Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America Anti-Infective Therapy Revenue, 2016-2027
  6.3.2 US Anti-Infective Therapy Market Size, 2016-2027
  6.3.3 Canada Anti-Infective Therapy Market Size, 2016-2027
  6.3.4 Mexico Anti-Infective Therapy Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe Anti-Infective Therapy Revenue, 2016-2027
  6.4.2 Germany Anti-Infective Therapy Market Size, 2016-2027
  6.4.3 France Anti-Infective Therapy Market Size, 2016-2027
  6.4.4 U.K. Anti-Infective Therapy Market Size, 2016-2027
  6.4.5 Italy Anti-Infective Therapy Market Size, 2016-2027
  6.4.6 Russia Anti-Infective Therapy Market Size, 2016-2027
  6.4.7 Nordic Countries Anti-Infective Therapy Market Size, 2016-2027
  6.4.8 Benelux Anti-Infective Therapy Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia Anti-Infective Therapy Revenue, 2016-2027
  6.5.2 China Anti-Infective Therapy Market Size, 2016-2027
  6.5.3 Japan Anti-Infective Therapy Market Size, 2016-2027
  6.5.4 South Korea Anti-Infective Therapy Market Size, 2016-2027
  6.5.5 Southeast Asia Anti-Infective Therapy Market Size, 2016-2027
  6.5.6 India Anti-Infective Therapy Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America Anti-Infective Therapy Revenue, 2016-2027
  6.6.2 Brazil Anti-Infective Therapy Market Size, 2016-2027
  6.6.3 Argentina Anti-Infective Therapy Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Anti-Infective Therapy Revenue, 2016-2027
  6.7.2 Turkey Anti-Infective Therapy Market Size, 2016-2027
  6.7.3 Israel Anti-Infective Therapy Market Size, 2016-2027
  6.7.4 Saudi Arabia Anti-Infective Therapy Market Size, 2016-2027
  6.7.5 UAE Anti-Infective Therapy Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 Abbott Laboratories Ltd.
  7.1.1 Abbott Laboratories Ltd. Corporate Summary
  7.1.2 Abbott Laboratories Ltd. Business Overview
  7.1.3 Abbott Laboratories Ltd. Anti-Infective Therapy Major Product Offerings
  7.1.4 Abbott Laboratories Ltd. Anti-Infective Therapy Revenue in Global (2016-2021)
  7.1.5 Abbott Laboratories Ltd. Key News
7.2 Cipla Ltd.
  7.2.1 Cipla Ltd. Corporate Summary
  7.2.2 Cipla Ltd. Business Overview
  7.2.3 Cipla Ltd. Anti-Infective Therapy Major Product Offerings
  7.2.4 Cipla Ltd. Anti-Infective Therapy Revenue in Global (2016-2021)
  7.2.5 Cipla Ltd. Key News
7.3 Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris))
  7.3.1 Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris)) Corporate Summary
  7.3.2 Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris)) Business Overview
  7.3.3 Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris)) Anti-Infective Therapy Major Product Offerings
  7.3.4 Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris)) Anti-Infective Therapy Revenue in Global (2016-2021)
  7.3.5 Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris)) Key News
7.4 Glenmark Pharmaceuticals Limited
  7.4.1 Glenmark Pharmaceuticals Limited Corporate Summary
  7.4.2 Glenmark Pharmaceuticals Limited Business Overview
  7.4.3 Glenmark Pharmaceuticals Limited Anti-Infective Therapy Major Product Offerings
  7.4.4 Glenmark Pharmaceuticals Limited Anti-Infective Therapy Revenue in Global (2016-2021)
  7.4.5 Glenmark Pharmaceuticals Limited Key News
7.5 GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd)
  7.5.1 GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd) Corporate Summary
  7.5.2 GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd) Business Overview
  7.5.3 GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd) Anti-Infective Therapy Major Product Offerings
  7.5.4 GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd) Anti-Infective Therapy Revenue in Global (2016-2021)
  7.5.5 GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd) Key News
7.6 Lupin Limited
  7.6.1 Lupin Limited Corporate Summary
  7.6.2 Lupin Limited Business Overview
  7.6.3 Lupin Limited Anti-Infective Therapy Major Product Offerings
  7.6.4 Lupin Limited Anti-Infective Therapy Revenue in Global (2016-2021)
  7.6.5 Lupin Limited Key News
7.7 Panacea Biotec Limited
  7.7.1 Panacea Biotec Limited Corporate Summary
  7.7.2 Panacea Biotec Limited Business Overview
  7.7.3 Panacea Biotec Limited Anti-Infective Therapy Major Product Offerings
  7.4.4 Panacea Biotec Limited Anti-Infective Therapy Revenue in Global (2016-2021)
  7.7.5 Panacea Biotec Limited Key News
7.8 Novartis AG
  7.8.1 Novartis AG Corporate Summary
  7.8.2 Novartis AG Business Overview
  7.8.3 Novartis AG Anti-Infective Therapy Major Product Offerings
  7.8.4 Novartis AG Anti-Infective Therapy Revenue in Global (2016-2021)
  7.8.5 Novartis AG Key News
7.9 Pfizer, Inc.
  7.9.1 Pfizer, Inc. Corporate Summary
  7.9.2 Pfizer, Inc. Business Overview
  7.9.3 Pfizer, Inc. Anti-Infective Therapy Major Product Offerings
  7.9.4 Pfizer, Inc. Anti-Infective Therapy Revenue in Global (2016-2021)
  7.9.5 Pfizer, Inc. Key News
7.10 Ranbaxy Laboratories Limited
  7.10.1 Ranbaxy Laboratories Limited Corporate Summary
  7.10.2 Ranbaxy Laboratories Limited Business Overview
  7.10.3 Ranbaxy Laboratories Limited Anti-Infective Therapy Major Product Offerings
  7.10.4 Ranbaxy Laboratories Limited Anti-Infective Therapy Revenue in Global (2016-2021)
  7.10.5 Ranbaxy Laboratories Limited Key News
7.11 Sun Pharmaceutical Industries Limited
  7.11.1 Sun Pharmaceutical Industries Limited Corporate Summary
  7.11.2 Sun Pharmaceutical Industries Limited Business Overview
  7.11.3 Sun Pharmaceutical Industries Limited Anti-Infective Therapy Major Product Offerings
  7.11.4 Sun Pharmaceutical Industries Limited Anti-Infective Therapy Revenue in Global (2016-2021)
  7.11.5 Sun Pharmaceutical Industries Limited Key News
7.12 AstraZeneca plc
  7.12.1 AstraZeneca plc Corporate Summary
  7.12.2 AstraZeneca plc Business Overview
  7.12.3 AstraZeneca plc Anti-Infective Therapy Major Product Offerings
  7.12.4 AstraZeneca plc Anti-Infective Therapy Revenue in Global (2016-2021)
  7.12.5 AstraZeneca plc Key News
7.13 Johnson & Johnson
  7.13.1 Johnson & Johnson Corporate Summary
  7.13.2 Johnson & Johnson Business Overview
  7.13.3 Johnson & Johnson Anti-Infective Therapy Major Product Offerings
  7.13.4 Johnson & Johnson Anti-Infective Therapy Revenue in Global (2016-2021)
  7.13.5 Johnson & Johnson Key News
7.14 WOCKHARDT
  7.14.1 WOCKHARDT Corporate Summary
  7.14.2 WOCKHARDT Business Overview
  7.14.3 WOCKHARDT Anti-Infective Therapy Major Product Offerings
  7.14.4 WOCKHARDT Anti-Infective Therapy Revenue in Global (2016-2021)
  7.14.5 WOCKHARDT Key News
7.15 F. Hoffmann-La Roche Ltd
  7.15.1 F. Hoffmann-La Roche Ltd Corporate Summary
  7.15.2 F. Hoffmann-La Roche Ltd Business Overview
  7.15.3 F. Hoffmann-La Roche Ltd Anti-Infective Therapy Major Product Offerings
  7.15.4 F. Hoffmann-La Roche Ltd Anti-Infective Therapy Revenue in Global (2016-2021)
  7.15.5 F. Hoffmann-La Roche Ltd Key News
7.16 Sanofi
  7.16.1 Sanofi Corporate Summary
  7.16.2 Sanofi Business Overview
  7.16.3 Sanofi Anti-Infective Therapy Major Product Offerings
  7.16.4 Sanofi Anti-Infective Therapy Revenue in Global (2016-2021)
  7.16.5 Sanofi Key News
7.17 Merck
  7.17.1 Merck Corporate Summary
  7.17.2 Merck Business Overview
  7.17.3 Merck Anti-Infective Therapy Major Product Offerings
  7.17.4 Merck Anti-Infective Therapy Revenue in Global (2016-2021)
  7.17.5 Merck Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES

Table 1. Anti-Infective Therapy Market Opportunities & Trends in Global Market
Table 2. Anti-Infective Therapy Market Drivers in Global Market
Table 3. Anti-Infective Therapy Market Restraints in Global Market
Table 4. Key Players of Anti-Infective Therapy in Global Market
Table 5. Top Anti-Infective Therapy Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Anti-Infective Therapy Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Anti-Infective Therapy Revenue Share by Companies, 2016-2021
Table 8. Global Companies Anti-Infective Therapy Product Type
Table 9. List of Global Tier 1 Anti-Infective Therapy Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Anti-Infective Therapy Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Anti-Infective Therapy Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Anti-Infective Therapy Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Anti-Infective Therapy Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Anti-Infective Therapy Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Anti-Infective Therapy Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Anti-Infective Therapy Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Anti-Infective Therapy Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Anti-Infective Therapy Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Anti-Infective Therapy Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Anti-Infective Therapy Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Anti-Infective Therapy Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Anti-Infective Therapy Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Anti-Infective Therapy Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Anti-Infective Therapy Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Anti-Infective Therapy Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Anti-Infective Therapy Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Anti-Infective Therapy Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Anti-Infective Therapy Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Anti-Infective Therapy Revenue, (US$, Mn), 2022-2027
Table 30. Abbott Laboratories Ltd. Corporate Summary
Table 31. Abbott Laboratories Ltd. Anti-Infective Therapy Product Offerings
Table 32. Abbott Laboratories Ltd. Anti-Infective Therapy Revenue (US$, Mn), (2016-2021)
Table 33. Cipla Ltd. Corporate Summary
Table 34. Cipla Ltd. Anti-Infective Therapy Product Offerings
Table 35. Cipla Ltd. Anti-Infective Therapy Revenue (US$, Mn), (2016-2021)
Table 36. Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris)) Corporate Summary
Table 37. Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris)) Anti-Infective Therapy Product Offerings
Table 38. Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris)) Anti-Infective Therapy Revenue (US$, Mn), (2016-2021)
Table 39. Glenmark Pharmaceuticals Limited Corporate Summary
Table 40. Glenmark Pharmaceuticals Limited Anti-Infective Therapy Product Offerings
Table 41. Glenmark Pharmaceuticals Limited Anti-Infective Therapy Revenue (US$, Mn), (2016-2021)
Table 42. GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd) Corporate Summary
Table 43. GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd) Anti-Infective Therapy Product Offerings
Table 44. GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd) Anti-Infective Therapy Revenue (US$, Mn), (2016-2021)
Table 45. Lupin Limited Corporate Summary
Table 46. Lupin Limited Anti-Infective Therapy Product Offerings
Table 47. Lupin Limited Anti-Infective Therapy Revenue (US$, Mn), (2016-2021)
Table 48. Panacea Biotec Limited Corporate Summary
Table 49. Panacea Biotec Limited Anti-Infective Therapy Product Offerings
Table 50. Panacea Biotec Limited Anti-Infective Therapy Revenue (US$, Mn), (2016-2021)
Table 51. Novartis AG Corporate Summary
Table 52. Novartis AG Anti-Infective Therapy Product Offerings
Table 53. Novartis AG Anti-Infective Therapy Revenue (US$, Mn), (2016-2021)
Table 54. Pfizer, Inc. Corporate Summary
Table 55. Pfizer, Inc. Anti-Infective Therapy Product Offerings
Table 56. Pfizer, Inc. Anti-Infective Therapy Revenue (US$, Mn), (2016-2021)
Table 57. Ranbaxy Laboratories Limited Corporate Summary
Table 58. Ranbaxy Laboratories Limited Anti-Infective Therapy Product Offerings
Table 59. Ranbaxy Laboratories Limited Anti-Infective Therapy Revenue (US$, Mn), (2016-2021)
Table 60. Sun Pharmaceutical Industries Limited Corporate Summary
Table 61. Sun Pharmaceutical Industries Limited Anti-Infective Therapy Product Offerings
Table 62. Sun Pharmaceutical Industries Limited Anti-Infective Therapy Revenue (US$, Mn), (2016-2021)
Table 63. AstraZeneca plc Corporate Summary
Table 64. AstraZeneca plc Anti-Infective Therapy Product Offerings
Table 65. AstraZeneca plc Anti-Infective Therapy Revenue (US$, Mn), (2016-2021)
Table 66. Johnson & Johnson Corporate Summary
Table 67. Johnson & Johnson Anti-Infective Therapy Product Offerings
Table 68. Johnson & Johnson Anti-Infective Therapy Revenue (US$, Mn), (2016-2021)
Table 69. WOCKHARDT Corporate Summary
Table 70. WOCKHARDT Anti-Infective Therapy Product Offerings
Table 71. WOCKHARDT Anti-Infective Therapy Revenue (US$, Mn), (2016-2021)
Table 72. F. Hoffmann-La Roche Ltd Corporate Summary
Table 73. F. Hoffmann-La Roche Ltd Anti-Infective Therapy Product Offerings
Table 74. F. Hoffmann-La Roche Ltd Anti-Infective Therapy Revenue (US$, Mn), (2016-2021)
Table 75. Sanofi Corporate Summary
Table 76. Sanofi Anti-Infective Therapy Product Offerings
Table 77. Sanofi Anti-Infective Therapy Revenue (US$, Mn), (2016-2021)
Table 78. Merck Corporate Summary
Table 79. Merck Anti-Infective Therapy Product Offerings
Table 80. Merck Anti-Infective Therapy Revenue (US$, Mn), (2016-2021)

LIST OF FIGURES

Figure 1. Anti-Infective Therapy Segment by Type
Figure 2. Anti-Infective Therapy Segment by Application
Figure 3. Global Anti-Infective Therapy Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Anti-Infective Therapy Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Anti-Infective Therapy Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Anti-Infective Therapy Revenue in 2020
Figure 8. By Type - Global Anti-Infective Therapy Revenue Market Share, 2016-2027
Figure 9. By Application - Global Anti-Infective Therapy Revenue Market Share, 2016-2027
Figure 10. By Region - Global Anti-Infective Therapy Revenue Market Share, 2016-2027
Figure 11. By Country - North America Anti-Infective Therapy Revenue Market Share, 2016-2027
Figure 12. US Anti-Infective Therapy Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Anti-Infective Therapy Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Anti-Infective Therapy Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Anti-Infective Therapy Revenue Market Share, 2016-2027
Figure 16. Germany Anti-Infective Therapy Revenue, (US$, Mn), 2016-2027
Figure 17. France Anti-Infective Therapy Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Anti-Infective Therapy Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Anti-Infective Therapy Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Anti-Infective Therapy Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Anti-Infective Therapy Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Anti-Infective Therapy Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Anti-Infective Therapy Revenue Market Share, 2016-2027
Figure 24. China Anti-Infective Therapy Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Anti-Infective Therapy Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Anti-Infective Therapy Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Anti-Infective Therapy Revenue, (US$, Mn), 2016-2027
Figure 28. India Anti-Infective Therapy Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Anti-Infective Therapy Revenue Market Share, 2016-2027
Figure 30. Brazil Anti-Infective Therapy Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Anti-Infective Therapy Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Anti-Infective Therapy Revenue Market Share, 2016-2027
Figure 33. Turkey Anti-Infective Therapy Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Anti-Infective Therapy Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Anti-Infective Therapy Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Anti-Infective Therapy Revenue, (US$, Mn), 2016-2027
Figure 37. Abbott Laboratories Ltd. Anti-Infective Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Cipla Ltd. Anti-Infective Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris)) Anti-Infective Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Glenmark Pharmaceuticals Limited Anti-Infective Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd) Anti-Infective Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Lupin Limited Anti-Infective Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Panacea Biotec Limited Anti-Infective Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Novartis AG Anti-Infective Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Pfizer, Inc. Anti-Infective Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. Ranbaxy Laboratories Limited Anti-Infective Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 47. Sun Pharmaceutical Industries Limited Anti-Infective Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 48. AstraZeneca plc Anti-Infective Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 49. Johnson & Johnson Anti-Infective Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 50. WOCKHARDT Anti-Infective Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 51. F. Hoffmann-La Roche Ltd Anti-Infective Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 52. Sanofi Anti-Infective Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)


More Publications